Cargando…

Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study

BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Junlin, Zhao, Yang, Zhang, Hongqi, Li, Tianxiao, Song, Donglei, Guan, Sheng, Maimaitili, Aisha, Wang, Yunyan, Feng, Wenfeng, Wang, Yang, Wan, Jieqing, Mao, Guohua, Shi, Huaizhang, Yang, Xinjian, Liu, Jianmin, Zhao, Yuanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442076/
https://www.ncbi.nlm.nih.gov/pubmed/37158157
http://dx.doi.org/10.1097/JS9.0000000000000467
_version_ 1785093507656974336
author Lu, Junlin
Zhao, Yang
Zhang, Hongqi
Li, Tianxiao
Song, Donglei
Guan, Sheng
Maimaitili, Aisha
Wang, Yunyan
Feng, Wenfeng
Wang, Yang
Wan, Jieqing
Mao, Guohua
Shi, Huaizhang
Yang, Xinjian
Liu, Jianmin
Zhao, Yuanli
author_facet Lu, Junlin
Zhao, Yang
Zhang, Hongqi
Li, Tianxiao
Song, Donglei
Guan, Sheng
Maimaitili, Aisha
Wang, Yunyan
Feng, Wenfeng
Wang, Yang
Wan, Jieqing
Mao, Guohua
Shi, Huaizhang
Yang, Xinjian
Liu, Jianmin
Zhao, Yuanli
author_sort Lu, Junlin
collection PubMed
description BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcome rates, as well as the learning curve for PED. METHODS: A total of 217 patients were consecutively enroled from four eligible centres and divided into three groups based on the number of procedures performed: group 1 (first 10 procedures), group 2 (11–20 procedures), and group 3(>20 procedures). Major complications include operation-related ischaemic or haemorrhagic events and mass effect deterioration. Poor outcome was defined as a modified Rankin Scale score greater than 2 at discharge. Cumulative summation (CUSUM) analysis was generated to assess the learning curve according to major complications and poor outcome. RESULTS: The study found that major complications and poor outcomes occurred in 5.1% and 2.3% of cases, respectively. The rate of major complications decreased from 10.0% in group 1 to 2.9% in group 3 (P=0.053), while the rate of poor outcomes decreased from 7.5% in group 1 to 0.7% in group 3 (P=0.015). Multivariable regression analysis adjusted for covariates showed that operator experience was associated with a lower rate of poor outcomes (P=0.034). CUSUM analysis demonstrated that the learning curve for avoiding major complications and poor outcomes required 27 (mean=13) and 40 (mean=20) cases, respectively. CONCLUSIONS: These findings suggest that PED treatment requires a learning curve of 40 cases to achieve reproducibility regarding complications and functional results. Additionally, major complications and poor outcomes significantly decreases after the first 20 procedures. CUSUM analysis can serve as a useful tool for monitoring and assessing surgical performance.
format Online
Article
Text
id pubmed-10442076
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104420762023-08-22 Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study Lu, Junlin Zhao, Yang Zhang, Hongqi Li, Tianxiao Song, Donglei Guan, Sheng Maimaitili, Aisha Wang, Yunyan Feng, Wenfeng Wang, Yang Wan, Jieqing Mao, Guohua Shi, Huaizhang Yang, Xinjian Liu, Jianmin Zhao, Yuanli Int J Surg Original Research BACKGROUND: Intracranial aneurysms pose a significant health issue, affecting 3–5% of the adult population. The pipeline embolization device (PED) has emerged as a promising treatment for these lesions. This study aimed to investigate the impact of operator experience on complication and poor outcome rates, as well as the learning curve for PED. METHODS: A total of 217 patients were consecutively enroled from four eligible centres and divided into three groups based on the number of procedures performed: group 1 (first 10 procedures), group 2 (11–20 procedures), and group 3(>20 procedures). Major complications include operation-related ischaemic or haemorrhagic events and mass effect deterioration. Poor outcome was defined as a modified Rankin Scale score greater than 2 at discharge. Cumulative summation (CUSUM) analysis was generated to assess the learning curve according to major complications and poor outcome. RESULTS: The study found that major complications and poor outcomes occurred in 5.1% and 2.3% of cases, respectively. The rate of major complications decreased from 10.0% in group 1 to 2.9% in group 3 (P=0.053), while the rate of poor outcomes decreased from 7.5% in group 1 to 0.7% in group 3 (P=0.015). Multivariable regression analysis adjusted for covariates showed that operator experience was associated with a lower rate of poor outcomes (P=0.034). CUSUM analysis demonstrated that the learning curve for avoiding major complications and poor outcomes required 27 (mean=13) and 40 (mean=20) cases, respectively. CONCLUSIONS: These findings suggest that PED treatment requires a learning curve of 40 cases to achieve reproducibility regarding complications and functional results. Additionally, major complications and poor outcomes significantly decreases after the first 20 procedures. CUSUM analysis can serve as a useful tool for monitoring and assessing surgical performance. Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10442076/ /pubmed/37158157 http://dx.doi.org/10.1097/JS9.0000000000000467 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Research
Lu, Junlin
Zhao, Yang
Zhang, Hongqi
Li, Tianxiao
Song, Donglei
Guan, Sheng
Maimaitili, Aisha
Wang, Yunyan
Feng, Wenfeng
Wang, Yang
Wan, Jieqing
Mao, Guohua
Shi, Huaizhang
Yang, Xinjian
Liu, Jianmin
Zhao, Yuanli
Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title_full Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title_fullStr Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title_full_unstemmed Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title_short Learning curve in pipeline embolization device: results from the pipeline embolization device in China post-market multicentre registry study
title_sort learning curve in pipeline embolization device: results from the pipeline embolization device in china post-market multicentre registry study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442076/
https://www.ncbi.nlm.nih.gov/pubmed/37158157
http://dx.doi.org/10.1097/JS9.0000000000000467
work_keys_str_mv AT lujunlin learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT zhaoyang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT zhanghongqi learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT litianxiao learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT songdonglei learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT guansheng learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT maimaitiliaisha learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT wangyunyan learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT fengwenfeng learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT wangyang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT wanjieqing learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT maoguohua learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT shihuaizhang learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT yangxinjian learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT liujianmin learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy
AT zhaoyuanli learningcurveinpipelineembolizationdeviceresultsfromthepipelineembolizationdeviceinchinapostmarketmulticentreregistrystudy